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Silicone oils are important tools in vitreoretinal surgery because they have the ability to displace aqueous humor from the retinal
surface, maintaining the adhesion between retina and retinal pigment epithelium. To understand this capability, it is important
to know the silicone oil characteristics. Herein, we report first on the main chemical-physical proprieties and then we review the
clinical applications of the current silicone oil which is lighter than water with particular reference to their indications with small
gauge vitrectomy. Finally, we describe the surgical techniques to inject and remove this type of silicone oil. In the summary of this
paper, we explain why silicone oils are today increasingly used and why their introduction has improved the prognosis of several
retinal diseases. In fact, having different types of silicone oils allows us to choose the appropriate endotamponade for every single
case.
1. Introduction
Silicone oils are important tools in vitreoretinal surgery and
their introduction has represented a pivotal moment in the
management of ophthalmic surgery as they are equippedwith
a combination of chemical and physical properties that have
propelled their surgical use [1]. Silicone oils are essentially
used as intraocular tamponade thanks to their ability to
maintain the adhesion between retina and retinal pigment
epithelium (RPE).
The safe and effective use of tamponade substancesmeans
the knowledge of their physical and chemical properties
because it is on the basis of this knowledge that surgeons have
to decide what type of tamponade they should use.
2. Physical Properties of Tamponades and
Clinical Consequences
To be effective as an internal tamponade, a silicone oil has to
have the ability to displace aqueous humor from the retinal
surface. The following 4 physical parameters influence this
function [2].
(1) Specific Gravity (SG). This explains why an intraocular
tamponade sinks or floats in aqueous humor. Any substances
with an SG of 1 are neutrally buoyant in water, those with SG
greater than 1 are denser than water and so will sink in it, and
thosewith an SGof less than 1 are less dense thanwater and so
will float. The specific gravity of aqueous humor and vitreous
humor is a little higher than that of water (SD 1.00). Since the
specific gravity of silicone oils in comparison is a little lower
(0.97), they float in vitreous cavity.
(2) Buoyancy. An intraocular bubble of tamponade agent is
acted upon by two opposing forces: buoyancy (upward force)
and the gravity on the bubble (downward force). Archimedes’
principle indicates that the upward buoyant force that is
exerted on a body immersed in a fluid, whether fully or
partially submerged, is equal to the weight of the fluid that
the body displaces. Archimedes’ principle is a fundamental
physics law of fluid mechanics. Regarding the vitreous cavity,
the result is the force with which the bubble presses against
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the retina. For silicone oil, the “pressing” force is relatively
small, as the specific gravity is close to that of aqueous humor.
The force is greatest with air or gas, as the specific gravity is
very low at 0.001.
(3) Interfacial Tension. When two immiscible agents are
used together (e.g., silicone oil and aqueous humor), the
interaction that occurs at the surface of these substances
involved is named interfacial tension. Interfacial tension is a
physical rating of the difference between the intermolecular
force of the two liquids and it is responsible for the shape of
liquid bubbles. Therefore, a substance with a high interfacial
tensionwill have a greater tendency to stay as one large bubble
without dispersion into small bubbles. Gas or air has the
highest interfacial tension against water (around 80mN/m),
whereas perfluorocarbon liquids (PFCLs) and silicone oils
have a lower interfacial tension, around 40–45mN/m and
35mN/m, respectively.
(4) Viscosity. The viscosity is the physical property of a fluid
which measures its resistance to gradual deformation by
shear stress. The tendency of a substance to emulsify and
disperse into droplets over time is also dependent on its
viscosity. The less viscous a substance, the lower the energy
that is required to disperse a large bubble of the substance
into small droplets. Silicone oils have a high viscosity (1.000–
5.000 cs) and, once dispersed, the small droplets will tend to
recoalesce back as a large bubble.
3. Chemical Properties
Silicone oil is a term generally used to describe a group of
hydrophobic polymeric and monomeric compounds consti-
tuted of silicon-oxygen bonds and named organosiloxane [3].
Because of their viscosity and their ability to repel water, they
are referred to as oils.
Silicone oils are constituted of a linear chain of siloxane
repeating units (–Si–O) and a variety of side chains (radical
side groups). Those used in ophthalmology have hydrocar-
bon radicals as radical side groups (e.g., methyl, phenyl, vinyl,
and trifluoropropyl groups). These composts are attached to
the silicon atom and it is possible to have many different
combinations. Therefore, one silicon atom can bond two
radical groups of the same type (e.g., dimethyl-siloxane) or
two different groups (e.g., phenyl-methyl-siloxane).
The major differences among silicone oils depend on
the molecular weight (MW), on the length of the linear
chain, and on the chemical structure of radical side groups,
radical end termination of the polymer chains, and the size
distribution of the chain. Thus, each type of silicone oil has
specific chemical and physical characteristics.
The viscosity of different types of silicone oil, which
is expressed in centistokes (1 cs = 10−6m2/s), arises from
the molecular weight and from the length of the polymers:
increasing a silicone oil’s molecular weight results in an
increased polymer chain length and consequently an increase
in its viscosity. Silicone oils currently used have a viscosity
ranging from 1.000 (MW 37 kDa) to 5.000 cs (MW 65 kDa).
In order to create a tamponade effect on the superior or
inferior retina, silicone oils have the capability to be lighter
or heavier than water and this property arises from the
radical side groups. Herein, we review the major indications
regarding the use of the first generation of silicone oils, which
is named lighter than water. They are the most commonly
used and are referred to as polydimethylsiloxane (PDMS).
Their viscosity rating is between 1000 and 30.000 cs.
4. Physical Properties
The aim of the use of silicone oil as vitreous substitute is
to provide short- to long-term tamponade of the retina.
The dynamic of the silicone oil depends on the interaction
between buoyancy, interfacial surface tension, and viscosity.
Buoyancy arises from the difference in specific gravity
between aqueous (or vitreous) humor and the selected
silicone oil. As we have seen at the beginning of this paper,
the specific gravity determines whether a vitreous substitute
will sink or float in aqueous humor. If compared with water
(specific gravity of 1.00), the specific gravity of aqueous
humor and vitreous humor is a little higher than this while
the gravity of silicone oil is a little lower (0.97). Therefore,
silicone oil floats inside the vitreous cavity and the upward
force is defined as buoyancy. This force is highest at the apex
and gradually decreases to zero at the horizontal meniscus.
Consequently, tamponade force arises from the difference
in density between aqueous humor, vitreous humor, and
silicone oil bubble. However, the buoyancy does not act upon
a single point but is spread over a limited area and, for this
reason, it produces pressure (force/unit area) [3].
Surface tension is responsible for the shape of liquid
droplets because it describes the forces that tend to keep
a bubble whole. In general, for 1000 cs silicone oil, it is
40mN/m (at 25∘C) that is approximately one-third of that
generated on an air bubble. There are several factors that
may influence the surface tension of a silicone oil bubble
once it is injected into the eye. First, the viscosity: the higher
the viscosity, the higher the surface tension. This is one
of the reasons why silicone oils with higher viscosity are
considered to emulsify less frequently than silicone oils with
lower viscosity.There are thenmany factors thatmay decrease
the surface tension: viscoelastic solutions, blood, proteins,
lipids, and ionized solutions (e.g., biological fluids) are factors
that, if present in the vitreous cavity when a silicone oil is
injected, can decrease the surface tension and therefore lead
to emulsification.
5. Does Viscosity Make a Real Difference in
Emulsification Rate?
A major permanent problem in the use of silicone oils as
vitreous substitutes is their tendency to emulsify. Emulsi-
fication means the formation of small oil droplets at the
interface between oil bubble and intraocular fluids or tissues
and it causes a dispersion of these droplets into the aqueous
humor and vitreous humor with consequently higher risk
of proliferative vitreoretinopathy, failed retinal detachment,
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inflammation, secondary glaucoma, and keratopathy, even
after silicone oil removal [4, 5].
In fact, once coated by emulsifiers, the droplets remain
dispersed, pass through retinal breaks or through the zonules
into the anterior segment, and cause inflammation and
activation of neutrophils [6].
The tendency to emulsify depends on several factors:
interfacial surface tension, viscosity, chemical composition,
content of low molecular weight (MW) siloxane compounds
or other impurities, and absorption of various biological
substances from intraocular fluids and tissues (named emul-
sifiers) have been studied and all of them can have a role in
the emulsification process [3].
The presence of a low MW siloxane compounds is very
critical. For a given viscosity, the silicone oil with the lowest
MW average will emulsify faster, while a purified silicone oil
with higher averageMWwill exhibit a better biocompatibility
and a higher resistance to the emulsification and therefore
the removal of low MW compounds during the purification
process of a silicone oil is very important.
Since a silicone oil with a higher viscosity has a lower
tendency to emulsify, many surgeons prefer these types
of silicone oil, such as 5000 cs, especially when the oil is
intended to serve as a prolonged or permanent tamponade.
However, although there are several studies demonstrating
in vitro that the increasing viscosity of silicone oil reduces
the tendency to emulsify [7–9], the commercially available
1000 cs and 5000 cs silicone oils do not have a clinically
significant difference in emulsification [10]. Despite their
difference in viscosity, the 1000 cs and 5000 cs silicone oils
have nearly the same behavior because in reality there are
many other determinant factors influencing the tendency
to emulsification: first, because, despite marked viscosity
difference, the 1000 cs and the 5000 cs silicone oils have nearly
the same surface tension (21.2mN/m and 21.3mN/m, resp.)
[3]; second, because, although the commercially available
preparations of 1000 cs and 5000 cs silicone oils have reached
a high grade of purity to minimize the risk of silicone oil
emulsification, the presence of impurities in the oil, such
as low MW molecules, may still occur; third, because, once
inside the vitreous cavity, silicone oil adsorbs biological
solutes from ocular fluids, blood, or tissue such as lipopro-
teins, cholesterol, and retinol [2, 3]. Each of these components
is an emulsifier because the contact of these substances with
the silicone oil bubble decreases their surface tension and
consequently increases the tendency to emulsify. Therefore,
it is easy to understand why in cases of hemorrhages and
inflammation or rather when the concentration of these
emulsifiers is high the risk of silicone oil emulsification is
higher.
Emulsification has been reported to occur after several
months. In a study of 150 eyes, Federman and Schubert [5]
found that emulsification of silicone oil occurred in 1% after
1 month, 11% at 3 months, 85% at 6 months, and 100% after
12 months. The emulsification seems to be therefore time
dependent [11] and it has been speculated that it depends on a
combination of the saccadic motion, the difference in density
of intraocular fluids and silicone oil, and the gradual decrease
of interfacial surface tension of the oil due to the adsorption
of surface-active components from the intraocular fluids [3,
8, 9].
With the advent of the Micro-Incisional Vitreoretinal
Surgery (MIVS) surgeons prefer less viscous silicone oils
which can be introduced and removed more easily through
the small instruments and cannulae. However, amore viscous
silicone oil would be less likely to emulsify. For this reason,
new silicone oils with an increasing extensional viscosity
have been studied [12–15]. These types of silicone oils are
obtained by the addition of a small amount (around 5–
10%) of very-long-chain silicone molecules to a common
silicone oil. The advantage of a silicone oil with an increasing
extensional viscosity would seem to be an increased resis-
tance to emulsification while maintaining a low viscosity
and therefore an easier injection and removal with small
gauge instrumentation with respect to single grade oils of
the equivalent shear viscosity. To date, there are only few
publications about the use of these new types of silicone
oils and all of them are in vitro tests. The main concept
raised from those tests is that silicone oil blends containing
small percentages of a high molecular weight of the same
chemical composition as the bulk oil are more resistant to
emulsification and are easier to inject than single grade oils
of the equivalent shear viscosity. However, there is only a
case report on their clinical use by Maier et al. in which
they reported two cases of early emulsification with a 2000 cs
silicone oil (Siluron 2000, Fluoron, Neu-Ulm, Germany)
[16]. Therefore, there is no evidence yet in the literature
whether these new types of silicone oil show lower tendency
to emulsify and therefore further clinical studies are needed.
6. Potential Complication Related to the
Postoperative IOP Control
Since a variety of complications are possible in case of a
vitreoretinal surgery, it is important to understand whether
they are associated with the use of silicone oil or related
to the underlying pathology and other aspects of surgical
intervention.
One of the main issues regarding the use of silicone
oils is the management of the postoperative IOP. In fact, a
postoperative IOP rise is not uncommon after vitrectomy
with silicone oil injection. In the Silicone Study a chronic
elevated IOP has been reported in the 8% of eyes treated
with conventional silicone oil at 36 months [17]. However,
in the literature, the incidence ranges from 2 to 40% [10, 18].
The causes of raised IOP aremultifactorial but, schematically,
there are 3 types of mechanisms.
(1) Pupillary block glaucoma: it may develop at any time
but it is more frequent in the early postoperative
time (days to some weeks). Aphakic eyes have more
risk compared to phakic/pseudophakic eyes. In either
case, the block originates when aqueous humor can-
not move in the anterior chamber due the presence
of silicone oil bubble with consequent aqueous mis-
direction, shallow anterior chamber, and raised IOP.
Therapy is to perform an inferior iridectomy (or
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reopen it) with YAG laser or tPA injection.Otherwise,
a second operation may be considered.
(2) Overfill of silicone oil: also this condition is more
frequent in the early postoperative period and it is
usually well treated with medical management. How-
ever, if the IOP remains too high, another operation
with partial removal of silicone may be necessary.
(3) Chronic elevation of IOP: while the first two mecha-
nisms were related to the presence of a whole silicone
oil bubble, a chronic elevation of the IOP is usually
related to a silicone emulsification and consequent
migration of silicone oil drops into the anterior
chamber angle. The emulsified droplets may obstruct
the trabecular meshwork and develop a trabeculitis.
For this reason, the therapy of this complication
consists in topical or periocular steroids, conventional
antiglaucoma drops, and, eventually, the removal of
silicone oil with careful attention to remove emul-
sified droplets from the anterior chamber. Unfortu-
nately, when the trabecular meshwork is permanently
damaged, the IOPdoes not return into a normal range
and therefore a glaucoma surgery may be required.
In this regard, glaucoma drainage devices have been
investigated for the treatment of refractory glaucoma.
Ishida et al. found that the chronically raised IOP can
be well controlled using the Ahmed glaucoma valve
even if the presence of silicone oil was associated with
an increased risk of surgical failure when compared
with eyes that had not been treated with silicone oil
[19]. However, in a case-control study by Wong et al.,
the authors found that the use of a heavy silicone oil
(Densiron-68) was associated with a higher IOP in
the early postoperative period when compared with
a conventional silicone oil [20].
7. Indications for Silicone Oil Tamponade
The history of silicone oil in ophthalmic surgery is very
short in comparison with gases. In the USA, in fact, silicone
oil as intraocular tamponade has been approved by the
Federal Drug Administration only in 1996. Since that date
its use has increased very fast. The first indications were
complicated retinal detachment due to PVR or viral retinitis,
giant retinal tears, trauma, and severe proliferative diabetic
retinopathy [21, 22]. New possible indications are now retinal
detachment due to macular hole in highly myopic eye
[23, 24], chronic and persistent macular hole, colobomatous
retinal detachment [25], and chronic uveitis with hypotony
[26]. In summary, every time a long-term tamponade is
required. Silicone oil has in fact the important advantage
of determining a long support until the recovery of the
retina has occurred. In case of retinal detachment, we usually
perform a silicone oil removal after 3–6 months because we
believe this time is sufficient for the recovery of the eye with
minimal risk for the development of a PVR.
Silicone oil is also the first choice for patients that
have to fly or for patients that cannot maintain the correct
postoperative positioning such as children or old patients.
The Silicone Oil Study, a prospective, multicentered,
randomized, controlled clinical trial comparing silicone oil
and long-acting gases in the management of eyes with severe
PVR, concluded that silicone oils were superior to sulfur
hexafluoride gas (SF6) and equivalent to perfluoropropane
gas (C3F8). If we consider however certain subgroups, it
appears clear that the use of silicone oil was better in case
of relaxing retinotomy, severe anterior PVR, difficulty in
maintaining the postoperative positioning, and the need to
fly or travel to higher altitudes. On the contrary, the use
of C3F8 had the relative indications for those cases with a
poor iris diaphragm due to a high probability of corneal
tamponade touch; superior retinal breaks on the posterior
edge of a scleral buckle, because gas conforms better than
silicone oil to the slope of the buckle; and the presence of a
silicone intraocular lens with an open posterior capsule [27–
29].
The rationale for silicone oil use in the management
of PDR is the reduction in postoperative hemorrhages and
the presence of a severe anterior segment neovascularization
[30]. This is because silicone oil may prevent the flow of
vasoproliferative factors into the anterior segment decreasing
the risk of iris rubeosis and neovascular glaucoma.Obviously,
we also use silicone oil after failure of conventional vitrectomy
for PDR due to the development of PVR.
The use of silicone oil for macular hole repair is very
controversial.We never use silicone oil as the first tamponade
of an idiopathic macular hole, except in some particular
cases. We prefer gas for many reasons. Gas has a higher
superficial tension and better buoyancy and does not need a
second surgery to remove it.This technique is well established
nowadays and the success rate with the use of gas is very
high [31]. We consider the use of silicone oil for selected and
particular cases in the treatment of idiopathic macular holes
when there are problems with the postoperative positioning,
air travel is necessary, or one-eyed patient.
Before the advent of PFCLs, silicone oil has been used
in the treatment of giant retinal tears both as intraocular
tool and as postoperative tamponade. As an intraocular
tool, silicone oil has been used to facilitate unfolding and
flattening of retinal tears and retinal detachment. Today, we
prefer for this purpose using PFCLs because they are easier
to use and because they unfold and flatten the retina less
traumatically. As permanent tamponade, silicone oils are
indeed very useful. While gases may be used to repair a
superior giant tear, in all other cases, we prefer silicone oil as
intraocular tamponade until we believe the retina recovered.
The advent and the improvement of the vitreoretinal
surgery have improved the prognosis of traumatized eye [32].
Silicone oils are used to minimize the risk of postoperative
bleeding, maintain retina attached, and avoid phthisis in case
of severely traumatized eyes. Often, several operations are
needed to obtain a reasonable anatomical and functional
outcome. After silicone oil removal, the high failure rate is
generally due to the development of a retinal detachment
and/or PVR that requires a new operation. In this regard,
since it is believed that the proliferative process continues for
a longer period of time than in eyes with nontraumatic retinal
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detachment, especially in case of penetrating ocular trauma,
it is recommended to leave silicone oil for several months.
8. Surgical Techniques
8.1. Silicone Oil Injection. Today, silicone oils are mainly used
as intraocular tamponade because the recent introduction of
PFCLs has decreased the use of silicone oils as intraoperative
tool.
With the modern vitrectomy systems, the injection and
the removal of silicone oils are performed using a syringe
connected to a pump that is controlled by the surgeon with
the foot-pedal. Since, according to Poiseuille’s law, the flow
of a fluid in a tube is proportional to the fourth power
of the radius of the tube and inversely proportional to the
length of the tube and due to the high viscosity and the
high pressure that is required to infuse silicone oils into
the vitreous cavity, special devices have been developed. The
system is therefore made of a large syringe, an infusion line
as short as possible, and nondistensible material. A large
syringe is required because it has to handle the high infusion
pressure, while a short infusion line is important to reduce the
resistance during the injection and the removal. The use of a
nondistensible material is important to avoid that, once the
injection is stopped, undesired further injection occurs when
the distended tube returns to its normal diameter, forcing
more silicone into the eye [33].
There are 3 surgical techniques to inject silicone oils into
the eye:
(i) fluid-silicone exchange,
(ii) air-silicone exchange,
(iii) perfluorocarbon liquid-silicone exchange (the so-
called direct exchange).
We do not perform a fluid-silicone exchange because, due
to the low surface tension, we believe that the risk is too high
that silicone oil enters the subretinal space through retinal
breaks. The choice of air, rather than perfluorocarbon liquid-
silicone exchange, depends on twomain reasons: the eventual
presence of a retinotomy or an anterior break. If the break
is in the mid periphery or at the posterior pole, we usually
perform first a fluid-air exchange with internal drainage of
subretinal fluid and then, once the retina is flattened under
air, an air-silicone exchange. If a relaxing retinotomy has been
applied or the retinal break is anterior, we prefer to perform
a direct exchange between PFCL and silicone oil in order to
avoid the slippage of the posterior edge of the tear. In this case,
we connect the syringe to the infusion line and an extrusion
needle is placed into the vitreous cavity. In this way, while
the surgeon injects the silicone oil pushing the foot-pedal,
either passive or active aspiration may be used to remove the
PFCL. In case of 23- or 25-gauge vitrectomy systems, we set
the machine with an aspiration rate from 0 to 30mmHg and
an infusion pressure rate from 0 to 28 Psi. It is important to
not exceed 30 Psi to avoid the disconnection of the infusion
line from the eye.
Regarding the management of the anterior segment,
particular attention has to be drawn to aphakic patients.
In these patients, an inferior peripheral iridectomy (IPI) is
mandatory to avoid pupillary block secondary to the silicone
oil filling. The IPI allows aqueous humor to pass under the
silicone oil bubble and to enter into the anterior chamber
without causing a pupillary block.
8.2. Silicone Oil Removal. Also, regarding silicone oil
removal, there are several techniques. Some surgeons prefer
to remove silicone oils using a two-port system, one for the
infusion line and another one to aspirate the tamponade.
Using this technique, it is also possible to passively remove
silicone oil through a small cornea incision in aphakic
eyes. At the end of the procedure, surgeons have to control
whether retina is still attached using a binocular indirect
ophthalmoscope. We do not use this technique anymore
for several reasons: first, because it is impossible to have a
direct control of the intraocular pressure and because it is
impossible to be sure that the silicone oil has been removed
completely. Finally, with this technique, it is impossible to
remove the silicone oils which are heavier than water.
We therefore always perform a standard three-port pars
plana vitrectomy also for silicone oil removal. We set the
machine with an IOP at 20–25mmHg and a vacuum rate
from 0 to 650mmHg. We currently use the new high-flow
extraction sleeve by Alcon that significantly improves oil
extraction compared with the old system, up to 5 times faster
depending on the gauge.The sleeve consists of a silicone tube
that is inserted on the head of the cannula (both 23- and 25-
gauge) and allows the aspiration of the silicone oil through the
cannula. To remove the sleeve from the cannula, it is enough
to exert a tilt motion, taking care to keep the head of the
cannula with a forceps (e.g., Bonn).
Once the silicone oil bubble has been removed, we
perform several fluid-air exchanges in order to remove every
small drop of silicone oil that remained inside the eye. In case
of emulsified drops in the anterior chamber, their removal
through a small corneal incision to minimize postoperative
risk of complications such as silicone keratopathy and sec-
ondary glaucoma is mandatory.
In phakic eyes, the decision whether or not to remove the
lens depends on the presence of a cataract and the patient’s
age. If there is a significant cataract, we usually remove the
lens during vitreoretinal surgery. If the crystalline lens is
clear, the decision arises from the age of the patient because
in patients older than 50 years we prefer to remove the
lens because the eye will develop a significant cataract few
months after the surgery. In this case, we perform a combined
phacoemulsification, posterior-chamber IOL implantation,
and silicone oil removal.
9. Conclusions
Silicone oils are very useful surgical tools because they are
able to simplify the surgical management of many vitreoreti-
nal diseases. With the modern vitrectomy systems and the
possibility to use such different tamponades, the prognosis of
several diseases has improved. According to the vitreoretinal
pathology, we can choose between a variety of silicone
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tamponades and we can therefore select the best intraocular
tamponade in relation to the underlying disease.
Depending on the situation and the duration of the
tamponade, we can decide which of the various character-
istics of an endotamponade would be the most important.
Nevertheless, we have to keep in mind that there are some
steps, such as complete removal of any traction, that are
crucial for the success of the surgery.
The decision of silicone oil usage may be taken both
before and during the operation. The first and more impor-
tant parameter of choice is the time that is, in surgeon’s
opinion, requested for the tamponade. Before the operation,
it is fundamental to take into consideration the type of
vitreoretinal disease (e.g., is there a PVR? And is the risk
of a surgical failure high?) and the postoperative position
because if we know that it is impossible for the patient (e.g.,
children) to maintain a certain postoperative positioning,
maybe it is better to choose silicone oil instead of another
tamponade. However, even if we have not programmed the
use of a permanent tamponade, it is possible to decide during
the operation that silicone oil is needed. For example, the
decision to perform a retinotomy or complications such as
an intraocular bleeding can indicate the choice of silicone oil.
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